New York State Common Retirement Fund Arbutus Biopharma Corp Transaction History
New York State Common Retirement Fund
- $76.2 Billion
- Q2 2024
A detailed history of New York State Common Retirement Fund transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, New York State Common Retirement Fund holds 44,968 shares of ABUS stock, worth $172,227. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,968
Previous 44,348
1.4%
Holding current value
$172,227
Previous $114,000
21.93%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ABUS
# of Institutions
137Shares Held
95.4MCall Options Held
3.44MPut Options Held
377K-
Morgan Stanley New York, NY21MShares$80.3 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY12.9MShares$49.3 Million30.08% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$44.2 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.57MShares$32.8 Million10.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.02MShares$26.9 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $574M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...